Xi‐Lei Zhou

1.3k total citations
23 papers, 1.1k citations indexed

About

Xi‐Lei Zhou is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Xi‐Lei Zhou has authored 23 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 12 papers in Pulmonary and Respiratory Medicine and 7 papers in Molecular Biology. Recurrent topics in Xi‐Lei Zhou's work include Esophageal Cancer Research and Treatment (10 papers), Lung Cancer Diagnosis and Treatment (7 papers) and Cancer-related molecular mechanisms research (6 papers). Xi‐Lei Zhou is often cited by papers focused on Esophageal Cancer Research and Treatment (10 papers), Lung Cancer Diagnosis and Treatment (7 papers) and Cancer-related molecular mechanisms research (6 papers). Xi‐Lei Zhou collaborates with scholars based in China. Xi‐Lei Zhou's co-authors include Yu‐Suo Tong, Qingquan Wu, Xiufeng Cao, Yingjian Song, Tongxin Yang, Xiaowei Wang, Jin Lv, Weiguo Zhu, Yaqi Song and Juan Tan and has published in prestigious journals such as Scientific Reports, Molecular Cancer and Neuroreport.

In The Last Decade

Xi‐Lei Zhou

23 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xi‐Lei Zhou China 13 550 497 336 290 286 23 1.1k
Itaru Omoto Japan 15 161 0.3× 222 0.4× 264 0.8× 237 0.8× 338 1.2× 48 810
Josefina Móra Spain 17 293 0.5× 279 0.6× 191 0.6× 355 1.2× 449 1.6× 58 949
I. D. Werner South Africa 11 473 0.9× 164 0.3× 239 0.7× 254 0.9× 454 1.6× 16 1.0k
Mehmet Akce United States 16 160 0.3× 187 0.4× 255 0.8× 275 0.9× 847 3.0× 115 1.2k
Ryu Shimada Japan 15 289 0.5× 281 0.6× 141 0.4× 206 0.7× 396 1.4× 48 811
Weiyu Xu China 14 244 0.4× 184 0.4× 169 0.5× 158 0.5× 185 0.6× 36 546
Kohei Shigeta Japan 15 157 0.3× 139 0.3× 210 0.6× 260 0.9× 590 2.1× 75 945
Yiping Du China 9 346 0.6× 259 0.5× 132 0.4× 128 0.4× 387 1.4× 13 703
Alis Dema Romania 12 117 0.2× 159 0.3× 177 0.5× 146 0.5× 172 0.6× 82 537

Countries citing papers authored by Xi‐Lei Zhou

Since Specialization
Citations

This map shows the geographic impact of Xi‐Lei Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xi‐Lei Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xi‐Lei Zhou more than expected).

Fields of papers citing papers by Xi‐Lei Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xi‐Lei Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xi‐Lei Zhou. The network helps show where Xi‐Lei Zhou may publish in the future.

Co-authorship network of co-authors of Xi‐Lei Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Xi‐Lei Zhou. A scholar is included among the top collaborators of Xi‐Lei Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xi‐Lei Zhou. Xi‐Lei Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Xi‐Lei, et al.. (2023). Reduction of acute radiation-induced brain injury in rats by anlotinib. Neuroreport. 35(2). 90–97. 3 indexed citations
2.
Xu, Yingying, Xi‐Lei Zhou, Changhua Yu, et al.. (2021). Association of Sarcopenia With Toxicity and Survival in Postoperative Recurrent Esophageal Squamous Cell Carcinoma Patients Receiving Chemoradiotherapy. Frontiers in Oncology. 11. 655071–655071. 9 indexed citations
3.
4.
Tong, Yu‐Suo, Lili Yang, Changhua Yu, et al.. (2020). Tumor-Secreted Exosomal lncRNA POU3F3 Promotes Cisplatin Resistance in ESCC by Inducing Fibroblast Differentiation into CAFs. Molecular Therapy — Oncolytics. 18. 1–13. 73 indexed citations
5.
Zhou, Xi‐Lei, Weiguo Zhu, Zhijian Zhu, et al.. (2019). Lymphopenia in Esophageal Squamous Cell Carcinoma: Relationship to Malnutrition, Various Disease Parameters, and Response to Concurrent Chemoradiotherapy. The Oncologist. 24(8). e677–e686. 29 indexed citations
6.
Zhou, Xi‐Lei, et al.. (2018). Combination of long noncoding RNA <em>MALAT1</em> and carcinoembryonic antigen for the diagnosis of malignant pleural effusion caused by lung cancer. OncoTargets and Therapy. Volume 11. 2333–2344. 17 indexed citations
7.
Tong, Yu‐Suo, Juan Tan, Xi‐Lei Zhou, Yaqi Song, & Yingjian Song. (2017). Systemic immune-inflammation index predicting chemoradiation resistance and poor outcome in patients with stage III non-small cell lung cancer. Journal of Translational Medicine. 15(1). 221–221. 174 indexed citations
8.
Zhou, Xi‐Lei, Yongqiang Li, Weiguo Zhu, et al.. (2017). Neutrophil-to-lymphocyte ratio as a prognostic biomarker for patients with locally advanced esophageal squamous cell carcinoma treated with definitive chemoradiotherapy. Scientific Reports. 7(1). 42581–42581. 43 indexed citations
9.
Tong, Yu‐Suo, Juan Tan, & Xi‐Lei Zhou. (2016). Clinical significance circulating long non-coding RNA H19 in plasma of patients with lung cancer. Chinese Journal of Asthma. 36(23). 1809–1813. 1 indexed citations
10.
Song, Yaqi, Xin-Le Kang, Gang Cao, et al.. (2016). Clinical characteristics and prognostic factors of brain central neurocytoma. Oncotarget. 7(46). 76291–76297. 9 indexed citations
11.
12.
Tong, Yu‐Suo, Xiaowei Wang, Xi‐Lei Zhou, et al.. (2015). Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma. Molecular Cancer. 14(1). 3–3. 287 indexed citations
13.
Song, Yaqi, Wanwei Wang, Guangzhou Tao, et al.. (2015). Survival benefit of radiotherapy to patients with small cell esophagus carcinoma - an analysis of Surveillance Epidemiology and End Results (SEER) data. Oncotarget. 7(13). 15474–15480. 8 indexed citations
14.
Tong, Yu‐Suo, Xi‐Lei Zhou, Xiaowei Wang, et al.. (2014). Association of decreased expression of long non-coding RNA LOC285194 with chemoradiotherapy resistance and poor prognosis in esophageal squamous cell carcinoma. Journal of Translational Medicine. 12(1). 233–233. 83 indexed citations
15.
16.
Pu, Juan, Shanshan Qin, Yan Zhang, et al.. (2013). A randomized controlled study of single-agent cisplatin and radiotherapy versus docetaxel/cisplatin and radiotherapy in high-risk early-stage cervical cancer after radical surgery. Journal of Cancer Research and Clinical Oncology. 139(4). 703–708. 20 indexed citations
17.
18.
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Itaru Omoto Breakdown of academic impact, for papers by Josefina Móra Breakdown of academic impact, for papers by I. D. Werner Breakdown of academic impact, for papers by Mehmet Akce Breakdown of academic impact, for papers by Ryu Shimada Breakdown of academic impact, for papers by Weiyu Xu Breakdown of academic impact, for papers by Kohei Shigeta Breakdown of academic impact, for papers by Yiping Du Breakdown of academic impact, for papers by Alis Dema
Rankless by CCL
2026